BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27893710)

  • 1. MUC1-C activates BMI1 in human cancer cells.
    Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
    Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.
    Tagde A; Markert T; Rajabi H; Hiraki M; Alam M; Bouillez A; Avigan D; Anderson K; Kufe D
    Oncotarget; 2017 Sep; 8(41):69237-69249. PubMed ID: 29050200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.
    Rajabi H; Hiraki M; Kufe D
    Oncogene; 2018 Apr; 37(16):2079-2088. PubMed ID: 29379165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
    Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
    Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
    Dimri M; Kang M; Dimri GP
    Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.
    Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D
    Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1-C activates EZH2 expression and function in human cancer cells.
    Rajabi H; Hiraki M; Tagde A; Alam M; Bouillez A; Christensen CL; Samur M; Wong KK; Kufe D
    Sci Rep; 2017 Aug; 7(1):7481. PubMed ID: 28785086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma.
    Wang HB; Liu GH; Zhang H; Xing S; Hu LJ; Zhao WF; Xie B; Li MZ; Zeng BH; Li Y; Zeng MS
    FEBS J; 2013 Jun; 280(12):2929-44. PubMed ID: 23601184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.
    Liu Y; Liu F; Yu H; Zhao X; Sashida G; Deblasio A; Harr M; She QB; Chen Z; Lin HK; Di Giandomenico S; Elf SE; Yang Y; Miyata Y; Huang G; Menendez S; Mellinghoff IK; Rosen N; Pandolfi PP; Hedvat CV; Nimer SD
    Sci Signal; 2012 Oct; 5(247):ra77. PubMed ID: 23092893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
    Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
    Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1-C drives MYC in multiple myeloma.
    Tagde A; Rajabi H; Bouillez A; Alam M; Gali R; Bailey S; Tai YT; Hideshima T; Anderson K; Avigan D; Kufe D
    Blood; 2016 May; 127(21):2587-97. PubMed ID: 26907633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
    Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
    Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
    Hata T; Rajabi H; Takahashi H; Yasumizu Y; Li W; Jin C; Long MD; Hu Q; Liu S; Fushimi A; Yamashita N; Kui L; Hong D; Yamamoto M; Miyo M; Hiraki M; Maeda T; Suzuki Y; Samur MK; Kufe D
    Cancer Res; 2019 Nov; 79(22):5711-5722. PubMed ID: 31519689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
    Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
    Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
    Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
    Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
    Hata T; Rajabi H; Yamamoto M; Jin C; Ahmad R; Zhang Y; Kui L; Li W; Yasumizu Y; Hong D; Miyo M; Hiraki M; Maeda T; Suzuki Y; Takahashi H; Samur M; Kufe D
    Mol Cancer Ther; 2019 Oct; 18(10):1744-1754. PubMed ID: 31308076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
    Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D
    J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
    Alam M; Bouillez A; Tagde A; Ahmad R; Rajabi H; Maeda T; Hiraki M; Suzuki Y; Kufe D
    Mol Cancer Res; 2016 Dec; 14(12):1266-1276. PubMed ID: 27658423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.
    Bednar F; Schofield HK; Collins MA; Yan W; Zhang Y; Shyam N; Eberle JA; Almada LL; Olive KP; Bardeesy N; Fernandez-Zapico ME; Nakada D; Simeone DM; Morrison SJ; Pasca di Magliano M
    Carcinogenesis; 2015 Jul; 36(7):730-8. PubMed ID: 25939753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.